Cargando…

Anti-Dementia Drug Persistence Following Donepezil Initiation Among Alzheimer’s Disease Patients in Japan: LIFE Study

BACKGROUND: Donepezil is frequently used to treat Alzheimer’s disease (AD) symptoms but is associated with early discontinuation. Determining the persistence rates of anti-dementia drug use after donepezil initiation may inform the development and improvement of treatment strategies, but there is li...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fukuda, Haruhisa, Maeda, Megumi, Murata, Fumiko, Murata, Yutaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741733/ https://www.ncbi.nlm.nih.gov/pubmed/36213993 http://dx.doi.org/10.3233/JAD-220200

Ejemplares similares

Development of a COVID-19 vaccine effectiveness and safety assessment system in Japan: The VENUS study
por: Fukuda, Haruhisa, et al.
Publicado: (2023)

Medical Care and Long-Term Care Expenditures Attributable to Alzheimer’s Disease Onset: Results from the LIFE Study
por: Fukuda, Haruhisa, et al.
Publicado: (2021)

Disease Burden and Progression in Patients with New-Onset Mild Cognitive Impairment and Alzheimer’s Disease Identified from Japanese Claims Data: Evidence from the LIFE Study
por: Fukuda, Haruhisa, et al.
Publicado: (2023)

Acute and delayed psychiatric sequelae among patients hospitalised with COVID-19: a cohort study using LIFE study data
por: Murata, Fumiko, et al.
Publicado: (2022)

Effectiveness of a Third Dose of COVID-19 mRNA Vaccine During the Omicron BA.1- and BA.2-Predominant Periods in Japan: The VENUS Study
por: Mimura, Wataru, et al.
Publicado: (2022)

Effect of COVID-19 Vaccination on Household Transmission of SARS-CoV-2 in the Omicron Era: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) study
por: Maeda, Megumi, et al.
Publicado: (2023)

Effectiveness of messenger RNA vaccines against infection with SARS-CoV-2 during the periods of Delta and Omicron variant predominance in Japan: the Vaccine Effectiveness, Networking, and Universal Safety (VENUS) study
por: Mimura, Wataru, et al.
Publicado: (2022)

Association between seasonal influenza vaccination and antimicrobial use in Japan from the 2015–16 to 2020–21 seasons: from the VENUS study
por: Tsuzuki, Shinya, et al.
Publicado: (2023)

Bivalent Vaccine Effectiveness Among Adults Aged ≥65 Years During the BA.5-Predominant Period in Japan: The VENUS Study
por: Mimura, Wataru, et al.
Publicado: (2023)

Multiregional Population-Based Cohort Study for Evaluation of the Association Between Herpes Zoster and mRNA Vaccinations for Severe Acute Respiratory Syndrome Coronavirus-2: The VENUS Study
por: Ishiguro, Chieko, et al.
Publicado: (2023)

Changes in percutaneous coronary intervention practice in Japan during the COVID‐19 outbreak: LIFE Study
por: Maeda, Megumi, et al.
Publicado: (2021)

Impact of Plasma Donepezil Concentration on Behavioral and Psychological Symptoms of Dementia in Patients with Alzheimer's Disease
por: Kagawa, Yoshiyuki, et al.
Publicado: (2021)

EPH51 Associations between Psychiatric Disorders and COVID-19 in Japan: Results from the Life Study
por: Murata, F, et al.
Publicado: (2022)

Donepezil structure-based hybrids as potential multifunctional anti-Alzheimer’s drug candidates
por: Piemontese, Luca, et al.
Publicado: (2018)

Development of a data platform for monitoring personal health records in Japan: The Sustaining Health by Integrating Next-generation Ecosystems (SHINE) Study
por: Fukuda, Haruhisa, et al.
Publicado: (2023)

Studies on Interaction of Buffalo Brain Cystatin with Donepezil: An Alzheimer's Drug
por: Amin, Fakhra, et al.
Publicado: (2013)

Efficacy of Galantamine on Cognition in Mild-to-Moderate Alzheimer's Dementia after Failure to Respond to Donepezil
por: Hwang, Tae-Young, et al.
Publicado: (2016)

Transdermal donepezil on the treatment of Alzheimer’s disease
por: Sozio, Piera, et al.
Publicado: (2012)

Drug Persistency Patterns for Patients Treated With Rivastigmine or Donepezil in Usual Care Settings
por: Mauskopf, Josephine A., et al.
Publicado: (2005)

Donepezil Beyond Alzheimer's Disease? A Narrative Review of Therapeutic Potentials of Donepezil in Different Diseases
por: Pooladgar, Parham, et al.
Publicado: (2022)

Donepezil and life expectancy in Alzheimer’s disease: A retrospective analysis in the Tajiri Project
por: Meguro, Kenichi, et al.
Publicado: (2014)

Regional Disparity of Reperfusion Therapy for Acute Ischemic Stroke in Japan: A Retrospective Analysis of Nationwide Claims Data from 2010 to 2015
por: Maeda, Megumi, et al.
Publicado: (2021)

Donepezil, Anti-Alzheimer's Disease Drug, Prevents Cardiac Rupture during Acute Phase of Myocardial Infarction in Mice
por: Arikawa, Mikihiko, et al.
Publicado: (2011)

Donepezil for Compulsive Behavior in Degenerative Dementia: Case Series
por: Mishra, Biswa Ranjan, et al.
Publicado: (2018)

Nationwide temporal trend analysis of reperfusion therapy utilization and mortality in acute ischemic stroke patients in Japan
por: Maeda, Megumi, et al.
Publicado: (2021)

Survey of psychiatric symptoms among inpatients with COVID-19 using the Diagnosis Procedure Combination data and medical records in Japan
por: Nakao, Tomohiro, et al.
Publicado: (2023)

Pd-Catalyzed Direct Modification of an Anti-Alzheimer’s Disease Drug: Synthesis and Biological Evaluation of α-Aryl Donepezil Analogues
por: Wan, Lin-Xi, et al.
Publicado: (2021)

Clinically meaningful treatment responses after switching to galantamine and with addition of memantine in patients with Alzheimer’s disease receiving donepezil
por: Kano, Osamu, et al.
Publicado: (2013)

Donepezil in Alzheimer’s disease: From conventional trials to pharmacogenetics
por: Cacabelos, Ramón
Publicado: (2007)

Donepezil enhances understanding of degraded speech in Alzheimer's disease
por: Hardy, Chris J. D., et al.
Publicado: (2017)

Donepezil Treatment for Alzheimer's Disease in Chronic Dialysis Patients
por: Yiannopoulou, Konstantina G., et al.
Publicado: (2019)

Withdrawal syndrome after donepezil cessation in a patient with dementia
por: Bidzan, Leszek, et al.
Publicado: (2012)

The Effects of an Uninterrupted Switch from Donepezil to Galantamine without Dose Titration on Behavioral and Psychological Symptoms of Dementia in Alzheimer's Disease
por: Sasaki, Shoichi, et al.
Publicado: (2014)

Two cases of Alzheimer’s disease showing deterioration of behavioral and psychological symptoms of dementia induced by switching from rivastigmine to donepezil
por: Kimura, Takemi, et al.
Publicado: (2013)

Effect of Psychoeducational Intervention on Donepezil Retention Rate and Analysis of Reasons for the Discontinuation in Patients with Alzheimer’s Dementia: A Randomized Study
por: Kamei, Tetsumasa, et al.
Publicado: (2021)

Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease
por: Unzeta, Mercedes, et al.
Publicado: (2016)

Effect of donepezil on transcranial magnetic stimulation parameters in Alzheimer's disease
por: Hwang, Yun Tae, et al.
Publicado: (2018)

Commentary: Donepezil enhances understanding of degraded speech in Alzheimer's disease
por: Campbell, Tom A., et al.
Publicado: (2018)

Donepezil Plus Solifenacin (CPC-201) Treatment for Alzheimer’s Disease
por: Chase, Thomas N., et al.
Publicado: (2017)

Donepezil for Dementia with Lewy Bodies: A Randomized, Placebo-Controlled Trial
por: Mori, Etsuro, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_gln4rj1j2cl2h8ekd2vkohc8ed